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ABSTRACT
Objective: The objective of the research is to design a new hydroxy xanthone derivative has anticancer activity using quantitative structure-activity 
relationship (QSAR).
Methods: The QSAR designed new compounds were calculated by parameterized model 3 methods and analysis of multi-linear regression (MLR).
Result: The result showed that the best model as follows:
LogIC50 = –9.132 qC1 + 28.853 qC5 + 2.456 qC6 – 7.375 qC10 – 5.112 qC11 + 3.900
This result has appropriate some statistical parameters (n=24; PRESS=0.999; r2=0.782; SEE=0. 235; R=0. 885; Fcal/Ftab=4.68).
Conclusion: This Model could be used to design of halogen-substituted hydroxy xanthone scaffold and predict their inhibitory concentration (IC50) as 
anticancer in the range of 0.001 - 0.484 μM.
Keywords: Anticancer, Quantitative structure-activity relationship, Xanthone.
INTRODUCTION
Cancer is the main cause of death worldwide. In 2012, there were 
8.2 million to 14.1 million cases of death all over the world. The highest 
rate of the death is caused by an inappropriate cancer treatment. So 
far, the treatment requires one or more interventions such as surgery, 
radiotherapy, and chemotherapy [1,2]. Chemotherapy is commonly 
used as the treatment options. However, the low selectivity and 
the high toxicity of anticancer drugs compromise the beneficial 
treatment effects of these agents [3-5]. Therefore, development of a 
new chemotherapeutic agent with high selectivity and low toxicity is 
important to be conducted.
Xanthones, were used in this study, comprise a large number of 
oxygenated heterocycles planar compounds which play an important 
role in medicinal chemistry. Their derivatives are widely distributed in 
various plants, and they have a variety of biological properties such as 
analgesic [6], anti-oxidant [7], anti-inflammatory [8], anti-allergic [9], 
anti-bacterial [10], anti-tuberculosis [11], anti-fungal [12], anti-viral [13], 
and also as anticancer such α-mangosteen and γ-mangosteen [14,15]. 
The simple structural scaffold and diverse pharmacological properties 
of xanthone derivatives have prompted many scientists to isolate these 
compounds from natural resources or synthesize them as novel drug 
candidates. Isolation method is not recommended because it gives a low 
yield of the isolated compound. Synthesis is one of the recommended 
ways to develop a new compound that has the best activity based on the 
understanding of structure modification by changing the substituents 
on the xanthone ring. However, this method has disadvantages over the 
time-consuming for “trial and error” and also cost during the synthesis.
One of the promising ways to develop a new therapeutic agent is to 
utilize the QSAR analysis into guiding the modification structure of 
the effective compounds. In the last decades, QSAR has been applied in 
many areas, particularly in the prediction of biological activities to save 
time and cost during the analysis. A QSAR equation is a mathematical 
equation related to the biological activity and wide variety of physical 
or chemical parameters. There were a lot of QSAR models mentioned 
in the literatures which have been successfully used for the screening 
of compounds and their biological activity [16-19]. The pre-requisite 
for developing QSAR equations is the availability of a wide range of 
molecular structures and their complementary activities. Nowadays, 
there are some researchers conducting the computational studies on 
xanthones, and they believe that it is critically important.
A QSAR study conducted by Alam and Khan [20] showed the prediction 
for specific targets such as HeLa cell using multi-linear regression 
(MLR) and optimizing their structures by MM + molecular mechanics. 
Their study showed that five molecular descriptors - dielectric energy, 
group count (hydroxyl), LogP (the logarithm of the partition coefficient 
between n-octanol and water), shape index basic (order 3), and the 
solvent-accessible surface area - were significantly correlated with 
anticancer activity. The other QSAR model was parameterized model 
3 (PM3) methods which being used to predict a series of xanthone 
derivatives as antimalarial compounds and showed that hydroxyl 
groups could influence their activity [21]. The QSAR model of a new 
series of xanthone derivatives against the oral human epidermoid 
carcinoma (KB) cancer cell was conducted by Suphavanich et al. [22]. 
They reported the combination of steric, electrostatic, hydrophobic 
and hydrogen-bond, which was calculated using 3D QSAR models, has 
satisfactory correlated to the test set activities. Practically, all of the 
QSAR models involved molecular descriptors. In this study, we focused 
on to find out the electronic descriptor which could affect the anticancer 
activity of xanthone derivatives.
In this study, a series of xanthone derivative compound using QSAR was 
carried out based on the data of the inhibitory concentration (IC50, μM) 
of xanthone derivatives from literatures [23-25]. The aim of this work 
focuses on finding establish new model which has chosen from the first 
step of study by selecting method of calculation of nuclear magnetic 
resonance (NMR) properties each model austin model 1 (AM1), PM3, 
Hartree-Fock (HF) level of theory, and density functional theory (DFT) 
methods. Based on these the best QSAR models, new compounds with 
highly predicted anticancer activity were theoretically designed, and 
they are waiting for experimental verification.
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This study used a PC with Intel® Core™ i3 CPU M 350 4.54 GHz; RAM 
5.00 GB. The used programs were Gaussian® 09W [26], statistical SPSS® 
Release 17.0.0 [27].
Data set
The structures of xanthone derivative compounds and its anticancer 
activity were divided into two sets as listed in Table 1. Namely a 
training set (19 compounds) for generating QSAR models and a test set 
(5 compounds) for validating the quality of the models. The selected 
compound of the training set and test set is an important feature and 
key of any QSAR models. Hence, the treatment was taken in such a way 
by biological activities of all tests set compounds with the maximum 
and minimum range of biological activities of the training set and test 
set compounds. The maximum and minimum data of training and 
test set were compared with: (i) The maximum data of the log IC50 of 
test set which should be less than or equal to the maximum value of 
log IC50 of training set, (ii) the minimum data of the log IC50 of test set 
that should be higher or equal to the minimum value of log ic50 of the 
training set [28].
Computational validation and descriptor calculation
Xanthone compounds were the first modeled computationally using 
AM1, PM3, HF, and DFT to obtain the most suitable calculation method 
and using the Gaussian package to calculate their chemical shift (NMR 
properties). The model with the smallest difference (PRESS value) 
between calculated and experimental data for each method (AM1, PM3, 
HF, or DFT) was chosen as the statistics of the training and test sets for 
QSAR calculation.
The development of QSAR model
The QSAR model was generated by the MLR Backward method using 
the SPSS package. This method refers to the dependent variable 
ŷ (biological activity) with a number of independent variables 
xi (electronic descriptors) by using linear equations. Moreover, this 
regression method estimates the values of the regression coefficients 
by applying least square curve fitting method. The model was chosen 
for QSAR calculation based on some statistical parameters such as r2, 
standard estimation of error (SEE), F-ratio between the variance of 
prediction and observation activity, and PRESS (predictive residual sum 
of square), where: PRESS = Σ (predicted value-observed value)2 [29] in 
criteria r2 > 0.6 [30]; SEE < 0.3 [31]; Fcal/Ftab≥ 1 [32].
The validation of QSAR model
The best-selected model obtained from the previous step was used to 
predict the Log IC50 of the test set. The model was validated by criteria 
r2prediction > 0.5 [33].
Design and activities prediction of the new compounds
The new designed and predicted xanthone derivative compounds based 
on the validated data with the best inhibitory activity and has lower 
IC50 value was chosen as a new candidate of the anticancer compound.
RESULT AND DISCUSSION
Validated method
The calculation of the chemical shift from each method (AM1, PM3, HF, 
and DFT) was compared with the experimental measurements to get the 
most suitable calculation method for modeling the series of xanthones 
derivatives with anticancer activity. The experimental measurement 
showed that the PM3 method gave the smallest difference (PRESS value) 
between calculated and experimental result. The correlation coefficient 
from each model was more than 0.99 (near 1) and listed in Table 2. 
Therefore, PM3 method has been selected as a calculation method for 
further modeling of anticancer activity of xanthones derivatives.
The selection method is important to improve the accuracy because the 
method of calculation giving smallest differences between calculated 
and experimental data validated method for the selection of methods 
of QSAR is also done in the design of new insecticide compounds have 
potent of organophosphate [34] with the results of AM1 method used 
for the analysis of advanced QSAR.
Generation and selection of QSAR model
Multiple linear regression analysis using SPSS version 17 for Windows 
has been performed to obtain the best model which correlates 
independent variables (descriptors) to a dependent variable 
(biological activity). QSAR analysis of this research was done to see the 
relationship between electronic variable against anticancer activity. 
Analysis of different from that done by previous researchers [10,11] 
that combines electronic and molecular variables. The use of electronic 
parameter because the electronic charge on ring xanthone can 
Table 1: A series of xanthone derivatives







7 9-oxo-9H-xanthene-1,3,6-triyl triacetate 1.602
8 1- hydroxy-3-methoxy-9H-xanthen-9-one 1.617
9 1- hydroxy -3-(oxyran-2-yl methoxy) -9H-xanthen-9-one 1.15
10 1- hydroxy -3-(2-(piperidine-1-yl) ethoxy) -9H-xanthen-9-one 1.47
11 3-(2,3-di hydroxy Propoxy) -1- hydroxy -9H-xanthen-9-one 1.354*
12 1,3-di hydroxy-12H-benzo [b] xanthen-12-one 0.928
13 1,3,7-tri hydroxy -12H-benzo[b] xanthen-12-one 0.611
14 9,11-dihydroxy-12H-benzo[b] xanthen-12-one 0.838*
15 1,5,8-trihydroxy-3-methoxy-2,4-bis (3-methylbut-2-en-1-yl)-9H-xanthen-9-one 1.594
16 6,9-dihydroxy-3,3-dimethyl-8-(3-methylbut-2-en-1-yl) pyrano[2,3-c] xanthen-7 (3H)-one 1.47
17 3-(4-(dimethylamino) butoxy) -1-hydroxy-12H-benzo [b] xanthen-12-one 0.545
18 3-(4-(diethylamino) butoxy) -1-hydroxy-12H-benzo [b] xanthen-12-one 0.879
19 1-hydroxy-3-(4-(pyrrolidin-1-yl) butoxy) -12H-benzo [b] xanthen-12-one 0.61
20 11-hydroxy-3-(4-(piperidin-1-yl) butoxy) -12H-benzo [b] xanthen-12-one 0.756
21 3-(2-(dimethylamino) ethoxy) -1-hydroxy-12H-benzo [b] xanthen-12-one 0.994
22 3-(3-(dimethylamino) Propoxy) -1-hydroxy-12H-benzo [b] xanthen-12-one 0.74
23 3-((5-(dimethylamino) pentyl) Oxy) -1-hydroxy-12H-benzo [b] xanthen-12-one 0.236
24 3-((6-(dimethylamino) hexyl) Oxy) -1-hydroxy-12H-benzo [b] xanthen-12-one 0.371*
*Test set compound
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describe the role or position of atoms which are the most influential 
on the anticancer activity. The 24 active compounds with their in vitro 
inhibition concentration were randomly divided into the training set of 
19 compounds and a test set of 5 compounds. 14 independent variables 
for electronic descriptor was described to consist of 14 atomic nets-
charges (q) of C1, C2, C3, C4, C5, C6, C7, C8, C9, C11, C12, O14, and 
O15. Of the 15 charges is difficult to determine the most dominant 
nets-atom effect, so the backward method was performed to gradually 
eliminate the less relevant variables from the models. This procedure 
has finally given 8 QSAR models as listed in Table 3. From the Table 3, it 
was emerged that all selected models show a good correlation (r ≈ 0.9) 
between biological activity and the selected descriptors.
This result indicated the determination of the best model among 8 QSAR 
models listed in Table 3 was not adequate only by comparing the r size, 
while they have similar value. Therefore, other statistical parameters 
such as r2, standard estimation of error (SEE<0.3), PRESS (predictive 
residual sum of square) and also Fcal/Ftab (≥1) could be taken into account. 
Comparison of the mentioned parameters (r2, SEE, PRESS, and Fcal/Ftab) 
toward the 8 models, presented in Table 3, pointed that it was also not 
easy to choose the best model because their value were not significantly 
different. However, Fcal/Ftab considered as the most noticeable parameter 
which give a variety of value from 1.26 to 3.99. According to this value, 
model 7 and 8 were decided to be the best QSAR model because their 
Fcal/Ftab value was the highest among the others (>3). Furthermore, model 
7 and 8 were used to search and design of new xanthones derivatives 
with better anticancer activity and their complete QSAR equations was, 
respectively, presented in Eq. 1 and Eq. 2 as below as:
Log IC50 = –9.378 qC1 + 31.283 qC5 + 3.962 qC6 -7.278 qC10 – 4.898 
qC11 + 4.135 (1)
Log IC50 = 19.633 qC5 + 6.458 qC6 – 5.731 qC11 + 3.986 (2)
The two equations above can be sure yet where that will be used 
to design new anticancer compound xanthone, if the terms of the 
simplicity of electronic parameter number of influential model equation 
8 or 2 the most good, but needs to be continued validation against both 
equations is obtained to ensure that the equation with parameters most 
appropriate statistics.
Validation of QSAR models
QSAR equation (1) and (2) was applied to calculate the activity of 5 test 
set compounds, and we could see how good these models predict the 
anticancer activity of the xanthone derivatives. A validation for searching 
the best model was performed using calculation for each equation toward 
the test set. The PRESS value is the amount of quadrate difference between 
the predicted and observed LogIC50 value, where the equation with the 
smallest difference was chosen as the best equation. PRESS value from the 
predicted and observed LogIC50 of model 7 and 8 were listed in Table 4.
Based on the PRESS parameter, the smallest PRESS value was shown by 
model 7, with 0.51 in difference, compared with model 8 with 0.69 in 
value. This result indicated that it has a small difference of anticancer 
activity as IC50 values within the predicted and experimental. It could be 
decided from PRESS value, that the model 7 was better than 8 as QSAR 
model to predict the anticancer activity and also it could give good 
structure of the predicted xanthone derivative compound.
Other parameters to convince the best model was with compared their 
slope and correlation coefficient (r2). As seen in Fig. 1, it was determined 
that r2 of model 7 and 8 were 0.861 and 0.556, respectively.
According to PRESS and r2 parameters of statistical analysis, model 7 with 
equation 1 would be the best QSAR model to generating the validation 
model toward the test set. Further validation for determining the best 
QSAR model was evaluated using enter statistical calculation. In the end, 
based on the calculation toward some statistical parameters, we found 
out the result as follows: PRESS=0.999, r2=0.7829, SEE=0. 235, R=0. 885, 
FCal/FTab=4.68. Plots of the predicted versus experimental of anticancer 
activity as Log IC50 values was shown in Fig. 2.
The correlation coefficient (r2) was 0.7829, it means there is 78.29% 
similarity value between predicted and experimental anticancer 
activity. Based on statistics obtained renewal of the parameter values of 
the equation 2, it could be generated the best equation model of QSAR 
regression as follows:
Log IC = –9.132 qC1 + 28.853 qC5 + 2.456 qC6 – 7.375 qC10 – 5.112 
qC11 + 3.900 (3)
Based on the Equation 3, electronic descriptors for electron charge 
of carbon atom in number 1, 5, 6, 10 and 11 (Fig. 3) Showed as the 
position with the most affect to the anticancer activity. The better 
anticancer activity as IC50 could be given by the more negative of the 
Table 3: Statistical parameters of 8 selected QSAR models of xanthones derivatives
Model Descriptors r R2 Adjusted R SEE PRESS FCalc/Ftab
1 qO14, qC8, qC6, qC7, qC10, qC12, qC1, qC11, qC4, qC13, qC5 0.93 0.86 0.642 0.26 0.47 1.26
2 qO14, qC8, qC6, qC10, qC12, qC1, qC11, qC4, qC13, qC5 0.93 0.86 0.686 0.24 0.47 1.58
3 qO14, qC6, qC10, qC12, qC1, qC11, qC4, qC13, qC5 0.93 0.86 0.719 0.23 0.47 1.97
4 qO14, qC6, qC10, qC12, qC1, qC11, qC4, qC5 0.92 0.85 0.735 0.22 0.50 2.32
5 qO14, qC6, qC10, qC1, qC11, qC4, qC5 0.92 0.84 0.747 0.21 0.52 2.76
6 qO14, qC6, qC10, qC1, qC11, qC5 0.91 0.82 0.734 0.22 0.60 2.98
7 qC6, qC10, qC1, qC11, qC5 0.90 0.80 0.726 0.22 0.473 3.38
8 qC6, qC10, qC11, qC5 0.88 0.78 0.717 0.23 0.74 3.99
SEE: Standard estimation of error, QSAR: Quantitative structure-activity relationship
Table 2: Comparison of calculated and experimental NMR 
chemical shift data (δ, ppm)
Number Experiment Calculated method
AM1 PM3 HF DFT
H-8 8.03 9.00 8.81 8.41 8.88
H-5 6.85 7.52 7.48 6.60 7.04
H-4 6.40 7.17 7.14 6.29 6.78
H-7 6.93 6.25 6.16 5.71 6.09
H-2 6.21 5.04 4.97 4.44 4.88
C-1 163.90 161.96 160.00 156.53 161.85
C-2 98.10 92.60 91.44 89.32 93.65
C-3 165.10 162.81 161.72 151.63 156.30
C-4 93.90 100.14 100.34 92.26 97.19
C-4a 158.00 162.03 161.80 157.48 162.08
C-5 102.30 106.96 106.77 100.91 105.84
C-6 164.10 161.67 160.19 156.26 161.39
C-7 113.80 93.46 105.28 103.65 106.66
C-8 127.50 134.08 132.48 111.25 115.09
C-8a 113.40 112.99 112.41 103.18 106.66
C-9 179.80 180.29 174.96 177.09 187.15
C-9a 102.50 104.18 105.28 98.23 102.58
C-10a 158.00 157.77 156.88 131.46 135.04
Correlation 0.995 0.997 0.995 0.994
PRESS 585.884 297.161 1587.065 983.388
NMR: Nuclear magnetic resonance, AM1: Austin model 1, PM3: Parameterized 
model 3, HF: Hartree-Fock, DFT: Density functional theory
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log IC50. To get the most negative value of logIC50, it was ordered by 
the negative net atomic charge of qC5 and qC6 and the positive net 
atomic charge of qC1, qC10, and qC11. From the Equation 3, qC5 and 
qC6 have positive value 28.853 and 2.456, respectively, so to make an 
electron net charge becoming negative, the C5 and C6 or neighbor’s 
position should be occupied with electron donating groups (EDG) 
such as hydroxy and methoxy group to make the π system more 
nucleophile. Meanwhile, the other positions such as C1, C10, and C11 
were supposed to fill up with electron withdrawing groups (EWG) 
such as nitro (–NO2) and also halogen (–X) to remove the electron 
density from the π system and make it less nucleophile or to make 
the net charge become positive. In other word, to make the net charge 
become negative, it is important to consider for adding the EDG and 
EWG groups on the best position to predict a series of xanthones 
derivatives with the best activity. Based on previous reports [35], it 
showed that the halohydrin (bromo and chloro) xanthones where 
the most effective inhibitors for Topo II, similar with doxorubicin as 
commercial cancer therapy, which has same inhibition activity. So in 
this study, it has been conducted to design a new hydroxy xanthone 
by modification of hydroxy xanthone scaffold with halogen groups, 
such as bromo, chloro and iodo, to look out their predicted anticancer 
activity, as listed as Table 5.
This research showed that there was a significant difference in the 
value of predicted Log IC50 compared with doxorubicin as commercial 
cancer therapy. This result indicates that the halogen-substituted 
hydroxy xanthone has potential to be developed as anticancer drugs, 
especially for HepG2 (human liver cancer) with predicted IC50 in the 
range of 0.001 - 0.484 μM, wherein it was lower than IC50 of doxorubicin 
at 3.83 μM [24]. Compounds predicted to also differ from other types 
of cancer as a result of the prediction by Alam and Khan [10] for 
HeLa cell cancer design derivatives of xanthone compounds hydroxy, 
methoxy, epoxy, and prenyl. While the special halogen compound 
bromo, and chloro is not done. Hence, the design of compound analysis 
results QSAR is a new xanthone derivative hydroxy compound with 
activity better value when compared to the values of IC50 cancer drug 
doxorubicin.
CONCLUSION
Study of the correlation between electronic parameters, atomic net 
charge, and the anticancer activity of xanthones has been performed 
using semi-empirical molecular orbital calculation PM-3. This study 
found out that the descriptors of atomic net charges: qC1, qC5, qC6, 
qC10, and qC11, were hypothetically active at the molecular site of 
xanthone derivatives and seem to be the most responsible for their 
pharmacological activity. The best QSAR regression equation from 
this study was revealed to be: Log IC50 = –9.132 qC1 + 28.853 qC5 
+ 2.456 qC6 - 7.375 qC10 - 5.112 qC11 + 3. 900. n=24, PRESS=0.999, 
r2=0.7829, SEE=0.235, R=0.885 and Fcal/Ftable=4.68. This QSAR model 
could predict a good inhibition activity (IC50) value of halogen-
substituted hydroxy xanthone derivatives within the range 0.001-
0.484 μM.
Table 5: New designed xanthones derivatives as anticancer and their predicted IC50 calculated using the best QSAR model
















Table 4: The comparison between predicted and experimental 
anticancer activity (Log IC50) of 5 test set selecting calculated by 










1 0.37 0.70 0.75
2 0.84 0.99 0.72
11 1.35 1.21 1.37
14 1.61 1.29 1.22
24 1.64 1.12 1.02
PRESS 0.51 0.69
Fig. 1: Plot of prediction versus experiment anticancer (Log IC50) of model 7 (a) and 8 (b)
ba
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Fig. 2: Plot of predicted versus experimental anticancer activity 
values of model 7
Fig. 3: Structure of xanthone
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